You are here

nexus

FDA's generic competition push hits Valeant's Isuprel, a price-hike poster child

Fierce Pharma

Tue, 08/8/17 - 10:03 am

Valeant Pharmaceuticals

Bayer Diagnostics, Axis-Shield alum to join ITC Nexus as CEO

Thu, 09/8/11 - 08:51 pm